21 Jun 2022 by admin in UncategorizedComments Arcellx Announces Closing Of Upsized Public Offering Of Common Stock And Underwriters’ Full Exercise Of Option To Purchase Additional Shares
21 Jun 2022 by admin in UncategorizedComments Arcellx Announces Appointment Of Maryam Abdul-Kareem As General Counsel
15 Jun 2022 by admin in UncategorizedComments Arcellx Announces Upsizing And Pricing Of Follow-On Public Offering
09 Jun 2022 by admin in UncategorizedComments Tempest Provides ASCO KOL Feedback on TPST-1120 Clinical Results and Updated Financial Guidance
23 May 2022 by admin in UncategorizedComments Arcellx Appoints Michelle Gilson As Chief Financial Officer
16 May 2022 by admin in UncategorizedComments Zenas BioPharma Submits Investigational New Drug Application in China for ZB001 for the Treatment of Thyroid Eye Disease
16 May 2022 by admin in UncategorizedComments Syros Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides a Corporate Update
